0001725160-24-000163.txt : 20241004
0001725160-24-000163.hdr.sgml : 20241004
20241004180121
ACCESSION NUMBER: 0001725160-24-000163
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20241004
FILED AS OF DATE: 20241004
DATE AS OF CHANGE: 20241004
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vultaggio Vincent
CENTRAL INDEX KEY: 0002018766
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39263
FILM NUMBER: 241355839
MAIL ADDRESS:
STREET 1: C/O ZENTALIS PHARMACEUTICALS, INC.
STREET 2: 530 SEVENTH AVENUE, SUITE 2201
CITY: NEW YORK
STATE: NY
ZIP: 10018
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zentalis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001725160
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 823607803
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10275 SCIENCE CENTER DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 263-4333
MAIL ADDRESS:
STREET 1: 10275 SCIENCE CENTER DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: Zentalis Pharmaceuticals, LLC
DATE OF NAME CHANGE: 20200107
FORMER COMPANY:
FORMER CONFORMED NAME: Zeno Pharma, LLC
DATE OF NAME CHANGE: 20171212
4
1
wk-form4_1728079274.xml
FORM 4
X0508
4
2024-10-04
0
0001725160
Zentalis Pharmaceuticals, Inc.
ZNTL
0002018766
Vultaggio Vincent
C/O ZENTALIS PHARMACEUTICALS, INC.
10275 SCIENCE CENTER DRIVE, SUITE 200
SAN DIEGO
CA
92121
0
1
0
0
Principal Accounting Officer
1
Common Stock
2024-10-04
4
S
0
1603
3.18
D
33855
D
A portion of the shares were sold automatically to satisfy withholding tax obligations upon the vesting of restricted stock units, and the remainder of the shares were sold pursuant to a Rule 10b5-1 instruction adopted by the Reporting Person on September 20, 2023.
/s/ Andrea Paul, attorney-in-fact for Vincent Vultaggio
2024-10-04